We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cancer Development: A Molecular Pathway Controls ErbB Signaling via PACS-2 Regulation of Recycling of the Metalloproteinase ADAM17

By LabMedica International staff writers
Posted on 13 Jul 2015
Print article
Image: Structure of the ADAM17 protein (Photo courtesy of Wikimedia Commons).
Image: Structure of the ADAM17 protein (Photo courtesy of Wikimedia Commons).
Some types of cancer are triggered by excessive ErbB signaling, and researchers have now discovered a molecular pathway that regulates this process.

The ErbB family of proteins contains four receptor tyrosine kinases, structurally related to the epidermal growth factor receptor (EGFR), its first discovered member. In humans, the family includes Her1 (EGFR, ErbB1), Her2 (Neu, ErbB2), Her3 (ErbB3), and Her4 (ErbB4). Insufficient ErbB signaling in humans is associated with the development of neurodegenerative diseases, such as multiple sclerosis and Alzheimer's disease, while excessive ErbB signaling is associated with the development of a wide variety of types of solid tumor. ErbB-1 and ErbB-2 are found in many human cancers, and their excessive signaling may be critical factors in the development and malignancy of these tumors.

Investigators at the University of Copenhagen (Denmark) were interested in how the metalloproteinase ADAM17 (ADAM metallopeptidase domain 17) activated ErbB signaling by releasing ligands from the cell surface, a key step underlying epithelial development, growth, and tumor progression.

"ADAM17 is very important to the growth of cancer tumors. It functions as a molecular pair of scissors, separating molecules from the cell's surface which then increases cell growth. The problem being that in cancer cells this growth is over-activated and so the cancer tumor grows rapidly and uncontrollably," said first author Dr. Sarah Dombernowsky, a post-doctoral researcher in the department of biomedicine at the University of Copenhagen.

Using a functional genome-wide siRNA (short interfering RNA) screen, the investigators identified the sorting protein PACS-2 (phosphofurin acidic cluster sorting protein 2) as a regulator of ADAM17 trafficking and ErbB signaling. PACS-2 is a multifunctional sorting protein that controls endoplasmic reticulum (ER)-mitochondria communication. It may also be involved in ion channel trafficking, directing acidic cluster-containing ion channels to distinct subcellular compartments.

PACS-2 loss reduced ADAM17 cell-surface levels and ADAM17-dependent ErbB ligand shedding, without apparent effects on related proteases. PACS-2 co-localized with ADAM17 on early endosomes, and PACS-2 knockdown decreased the recycling and stability of internalized ADAM17. Therefore, PACS-2 sustained ADAM17 cell-surface activity by diverting ADAM17 away from degradative pathways.

"We have discovered that the protein PACS-2 plays a big part in the transportation of ADAM17 in cells," said Dr. Dombernowsky. "ADAM17 moves in and out of the cell, but it has to remain on the surface to be able to cut off molecules and thus further growth. We have showed that without the PACS-2, ADAM17 returns less regularly to the surface; it is broken down instead. We are currently experimenting on mice to see if the cancer growth slows down, and it is our distinct expectation that it will. In the long-term, we would like to develop something that through PACS-2 allows us to fine-tune ADAM17, which could then eventually become part of a more targeted cancer treatment."

The study was published in the June 25, 2015, online edition of the journal Nature Communications.

Related Links:
University of Copenhagen


Gold Member
Troponin T QC
Troponin T Quality Control
Unit-Dose Packaging solution
HLX
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.